Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG): Updated follow-up from KEYNOTE-057.

被引：2
|
作者：
De Wit, Ronald
Kulkarni, Girish S.
Uchio, Edward M.
Krieger, Laurence Eliot Miles
Boormans, Joost L.
Roumiguie, Mathieu
Singer, Eric A.
Bajorin, Dean F.
Kamat, Ashish M.
Grivas, Petros
Seo, Ho Kyung
Nishiyama, Hiroyuki
Konety, Badrinath R.
Nam, Kijoeng
Kapadia, Ekta
Frenkl, Tara L.
Balar, Arjun Vasant
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Univ Toronto, UHN Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] UC Irvine Hlth, Orange, CA USA
[4] Royal North Shore Hosp, Northern Canc Inst, St Leonards, NSW, Australia
[5] Inst Univ Canc Toulouse Oncopole CHU, Toulouse, France
[6] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Univ Washington, Seattle, WA 98195 USA
[10] Natl Canc Ctr, Goyang, South Korea
[11] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[12] Univ Minnesota, Minneapolis, MN USA
[13] Merck & Co Inc, Kenilworth, NJ USA
[14] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4530
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Outcomes of patients with bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer who demonstrated non-response to pembrolizumab in KEYNOTE-057: A post hoc analysis
    Li, Roger
    Linscott, Joshua
    Kulkarni, Girish S.
    Necchi, Andrea
    Roumiguie, Mathieu
    Singer, Eric A.
    Uchio, Edward M.
    Boormans, Joost L.
    Xing, Aiwen
    Van den Sigtenhorst, Margot
    Kapadia, Ekta
    Kamat, Ashish M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] The Management of Bacillus Calmette-Guerin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article
    Kodera, Ahmed
    Mohammed, Mahmoud
    Lim, Paul
    Abdalla, Omer
    Elhadi, Mohammed
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [33] Atezolizumab plus intravesical BCG (Bacillus Calmette-Guerin) in high-risk non-muscle invasive bladder cancer (NMIBC) patients: Institutional clinical and translational study (BladderGATE)
    Castellano, Daniel
    de Velasco, Guillermo
    Martin Soberon, Maria Cruz
    Carretero-Gonzalez, Alberto
    Duenas, Marta
    Paramio, Jesus
    De la Rosa, Federico
    Luis Sanz, Juan
    Guerrero, Felix
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [34] HEALTHCARE RESOURCE USE (HCRU) OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS POST BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE STATUS IN MULTIPLE COUNTRIES
    Broughton, E.
    Chun, D.
    Gooden, K.
    Mycock, K.
    Rajkovic, I
    Taylor-Stokes, G.
    [J]. VALUE IN HEALTH, 2020, 23 : S484 - S485
  • [35] Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guerin for patients with high-risk non-muscle invasive bladder cancer
    Jamil, Marcus L.
    Deebajah, Mustafa
    Sood, Akshay
    Robinson, Kathy
    Rao, Krishna
    Sana, Sherjeel
    Alanee, Shaheen
    [J]. BMJ OPEN, 2019, 9 (07):
  • [36] The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
    Racioppi, Marco
    Di Gianfrancesco, Luca
    Ragonese, Mauro
    Palermo, Giuseppe
    Sacco, Emilio
    Bassi, PierFrancesco
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (05) : 507 - 512
  • [37] Urinary cytokine profiles reflect rationale for treatment with gemcitabine and Bacillus Calmette-Guerin (BCG) in BCG-exposed high-risk non-muscle invasive bladder cancer (NMIBC)
    Gaffney, Christopher D.
    Alam, Syed M.
    Lavery, Jessica A.
    Basar, Merve
    D'Souza, Neeta
    Hernandez, Christian
    McCarter, Melissa
    Moran, Patricia
    Stasi, Kristen
    Worth, Kara
    Sjoberg, Daniel
    Dalbagni, Guido
    Donahue, Timothy
    Donat, Sherri
    Bajorin, Dean
    Bochner, Bernard H.
    Goh, Alvin
    Sarungbam, Judy
    Al-Ahmadie, Hikmat
    Pietzak, Eugene J.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [38] CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Steinberg, Gary D.
    Li, Roger
    Lamm, Donald
    Uchio, Edward
    Packiam, Vignesh
    Kamat, Ashish
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 319 - 319
  • [39] PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward
    Lamm, Donald
    Paras, Shah
    Kamat, Ashish
    Bivalacqua, Trinity
    Packiam, Vignesh
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A696 - A696
  • [40] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed M.
    Shah, Paras
    Kamat, Ashish M.
    Hnat, Nataliya
    Chisamore, Michael J.
    Grandi, Paola
    Burke, James
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E927
12345